Here below are the publications (5) participated by Alberto Jesus Arribas along with Georg Stussi (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations).
Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch

1) PI3Kδ activation, IL6 over-expression, and CD37 loss cause resistance to the targeting of CD37-positive lymphomas with the antibody-drug conjugate naratuximab emtansine
bioRxiv, 16 novembre 2023

2) ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms
bioRxiv, 2 gennaio 2023

3) Resistance to PI3Kδ inhibitors in marginal zone lymphoma can be reverted by targeting the IL-6/PDGFRA axis
Haematologica, 1 novembre 2022

4) Genetic and phenotypic attributes of splenic marginal zone lymphoma
Blood, 3 febbraio 2022

5) Targeting CD205 with the antibody drug conjugate MEN1309/OBT076 is an active new therapeutic strategy in lymphoma models
Haematologica, 1 novembre 2020